509 Results for "

Oral availability

" in MedChemExpress (MCE) Product Catalog:
Products (509)

509 Results for "Oral availability" in MCE Product Catalog:

141
141 Publications Verification
Referencia número: HY-18072
No. CAS: 1337531-36-8
Target:  

PERK Autophagy Apoptosis

Áreas de investigación:  

Cancer

GSK2606414 is a cell-permeable and orally available protein kinase R-like endoplasmic reticulum (ER) kinase (PERK) inhibitor with an IC50 of 0.4 nM.
loading...
    loading...
120
120 Cited Publications
Referencia número: HY-108413
No. CAS: 1373431-65-2
Pureza:  99.95%
Synonyms: BMN 673ts
Target:  

PARP

Áreas de investigación:  

Cancer

Talazoparib tosylate (BMN 673ts) is a novel, potent and orally available PARP1/2 inhibitor with an IC50 of 0.57 nM for PARP1.
loading...
    loading...
106
106 Cited Publications
Referencia número: HY-13803
No. CAS: 1403254-99-8
Pureza:  99.93%
Synonyms: EPZ-6438; E-7438
Áreas de investigación:  

Inflammation/Immunology Cancer

Tazemetostat (EPZ-6438) is a potent, selective and orally available EZH2 inhibitor. Tazemetostat inhibits the activity of human polycomb repressive complex 2 (PRC2)-containing wild-type EZH2 with a Ki value of 2.5 nM. Tazemetostat inhibits EZH2 with IC50s of 11 and 16 nM in peptide assay and nucleosome assay, respectively. Tazemetostat inhibits rat EZH2 with an IC50 of 4 nM. Tazemetostat also inhibits EZH1 with an IC50 of 392 nM. Tazemetostat induces apoptosis and differentiation specifically in SMARCB1-deleted MRT cells .
loading...
    loading...
76
76 Cited Publications
Referencia número: HY-100388A
No. CAS: 2200214-93-1
Pureza:  99.87%
Target:  

SHP2 Phosphatase

Áreas de investigación:  

Cancer

SHP099 hydrochloride is a potent, selective and orally available SHP2 inhibitor with an IC50 of 70 nM .
loading...
    loading...
68
68 Cited Publications
Referencia número: HY-130149
No. CAS: 2326521-71-3
Pureza:  99.81%
Synonyms: MRTX849
Target:  

Ras

Áreas de investigación:  

Cancer

Adagrasib (MRTX849) is a potent, orally-available, and mutation-selective covalent inhibitor of KRAS G12C with potential antineoplastic activity. Adagrasib covalently binds to KRAS G12C at the cysteine at residue 12, locks the protein in its inactive GDP-bound conformation, and inhibits KRAS-dependent signal transduction .
loading...
    loading...
57
57 Cited Publications
Referencia número: HY-19741
No. CAS: 1430844-80-6
Target:  

Bcl-2 Family

Áreas de investigación:  

Cancer

A-1331852 is an orally available BCL-XL selective inhibitor with a Ki of less than 10 pM.
loading...
    loading...
54
54 Cited Publications
Referencia número: HY-10159
No. CAS: 641571-10-0
Pureza:  99.94%
Synonyms: AMN107
Target:  

Bcr-Abl Autophagy

Áreas de investigación:  

Cancer

Nilotinib is an orally available Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity.
loading...
    loading...
47
47 Cited Publications
Referencia número: HY-13011
No. CAS: 1256580-46-7
Pureza:  99.78%
Synonyms: CH5424802; RO5424802; RG7853
Áreas de investigación:  

Neurological Disease Cancer

Alectinib (CH5424802; RO5424802; RG7853) is a potent, selective, and orally available ALK inhibitor with an IC50 of 1.9 nM and a Kd value of 2.4 nM (in an ATP-competitive manner), and also inhibits ALK F1174L and ALK R1275Q with IC50s of 1 nM and 3.5 nM, respectively . Alectinib demonstrates effective central nervous system (CNS) penetration .
loading...
    loading...
47
47 Cited Publications
Referencia número: HY-13011A
No. CAS: 1256589-74-8
Pureza:  99.92%
Synonyms: CH5424802 Hydrochloride; RO5424802 Hydrochloride; AF-802 Hydrochloride
Áreas de investigación:  

Neurological Disease Cancer

Alectinib (CH5424802; RO5424802; RG7853) Hydrochloride is a potent, selective, and orally available ALK inhibitor with an IC50 of 1.9 nM and a Kd value of 2.4 nM (in an ATP-competitive manner), and also inhibits ALK F1174L and ALK R1275Q with IC50s of 1 nM and 3.5 nM, respectively . Alectinib demonstrates effective central nervous system (CNS) penetration .
loading...
    loading...
43
43 Cited Publications
Referencia número: HY-18708
No. CAS: 1346242-81-6
Synonyms: JNJ-42756493
Target:  

FGFR Apoptosis

Áreas de investigación:  

Cancer

Erdafitinib (JNJ-42756493) is a potent and orally available FGFR family inhibitor; inhibits FGFR1/2/3/4 with IC50s of 1.2, 2.5, 3.0 and 5.7 nM, respectively.
loading...
    loading...
41
41 Cited Publications
Referencia número: HY-12067
No. CAS: 841290-81-1
Pureza:  96.70%
Target:  

Syk FLT3 Apoptosis

Áreas de investigación:  

Inflammation/Immunology Cancer

R406 is an orally available and competitive Syk/FLT3 inhibitor for ATP binding with a Ki of 30 nM, potently inhibits Syk kinase activity in vitro with an IC50 of 41 nM, measured at an ATP concentration corresponding to its Km value. R406 reduces immune complex-mediated inflammation . R406 also inhibits Lyn (IC50=63 nM) and Lck (IC50=37 nM) .
loading...
    loading...
41
41 Cited Publications
Referencia número: HY-11108
No. CAS: 841290-80-0
Pureza:  99.80%
Target:  

Syk FLT3 Apoptosis

Áreas de investigación:  

Inflammation/Immunology Cancer

R406 free base is an orally available and competitive Syk/FLT3 inhibitor for ATP binding with a Ki of 30 nM, potently inhibits Syk kinase activity in vitro with an IC50 of 41 nM, measured at an ATP concentration corresponding to its Km value. R406 free base reduces immune complex-mediated inflammation . R406 free base also inhibits Lyn (IC50=63 nM) and Lck (IC50=37 nM) .
loading...
    loading...
39
39 Cited Publications
Referencia número: HY-136927
No. CAS: 129425-81-6
Pureza:  99.81%
Target:  

STING

Áreas de investigación:  

Inflammation/Immunology Cancer

MSA-2, a potent and orally available non-nucleotide STING agonist, is bound to STING as a noncovalent dimer with nanomolar affinity. MSA-2 shows EC50s of 8.3 and 24 μM for human STING isoforms WT and HAQ, respectively. MSA-2 stimulates interferon-β secretion in tumors, induces tumor regression with durable antitumor immunity, and synergizes with anti-PD-1 in syngeneic mouse tumor models .
loading...
    loading...
31
31 Cited Publications
Referencia número: HY-32721
No. CAS: 698387-09-6
Synonyms: HKI-272
Target:  

EGFR

Áreas de investigación:  

Cancer

Neratinib (HKI-272) is an orally available, irreversible, highly selective HER2 and EGFR inhibitor with IC50s of 59 nM and 92 nM, respectively .
loading...
    loading...
31
31 Cited Publications
Referencia número: HY-32721B
No. CAS: 915942-22-2
Synonyms: HKI-272 maleate
Target:  

EGFR

Áreas de investigación:  

Cancer

Neratinib (HKI-272) maleate is an orally available, irreversible, highly selective HER2 and EGFR inhibitor with IC50s of 59 nM and 92 nM, respectively .
loading...
    loading...
31
31 Cited Publications
Referencia número: HY-18300
No. CAS: 1206161-97-8
Synonyms: GLPG0634
Target:  

JAK HIV

Áreas de investigación:  

Cancer

Filgotinib (GLPG0634) is a selective, orally available JAK1 inhibitor with anti-inflammatory and antiviral activities. Filgotinib can effectively inhibit the activities of JAK1, JAK2, JAK3 and TYK2 with IC50 values of 10 nM, 28 nM, 810 nM and 116 nM, respectively. Filgotinib also inhibits HIV-1 driven gene transcription and reduces proliferation of HIV-1 infected cells. Filgotinib can be used in the study of rheumatoid arthritis and inflammatory bowel disease .
loading...
    loading...
31
31 Cited Publications
Referencia número: HY-18300A
No. CAS: 1802998-75-9
Synonyms: GLPG0634 maleate
Target:  

JAK HIV

Áreas de investigación:  

Inflammation/Immunology

Filgotinib maleate (GLPG0634 maleate) is a selective, orally available JAK1 inhibitor with anti-inflammatory and antiviral activities. Filgotinib maleate can effectively inhibit the activities of JAK1, JAK2, JAK3 and TYK2 with IC50 values ​​of 10 nM, 28 nM, 810 nM and 116 nM, respectively. Filgotinib maleate also inhibits HIV-1 driven gene transcription and reduces proliferation of HIV-1 infected cells. Filgotinib maleate can be used in the study of rheumatoid arthritis and inflammatory bowel disease .
loading...
    loading...
28
28 Cited Publications
Referencia número: HY-12296
No. CAS: 1352066-68-2
Pureza:  99.61%
Synonyms: AMG 232; KRT-232
Áreas de investigación:  

Cancer

Navtemadlin (AMG 232) is a potent, selective and orally available inhibitor of p53-MDM2 interaction, with an IC50 of 0.6 nM. Navtemadlin binds to MDM2 with a Kd of 0.045 nM .
loading...
    loading...
25
25 Cited Publications
Referencia número: HY-112134
No. CAS: 2375740-98-8
Pureza:  99.95%
Target:  

Deubiquitinase

Áreas de investigación:  

Cancer

CSN5i-3 is a potent, selective and orally available inhibitor of CSN5/Jab1, and inhibits CSN-catalysed Cul1 deneddylation with an IC50 value of 5.8 nM .
loading...
    loading...
23
23 Cited Publications
Referencia número: HY-12727
No. CAS: 1616391-65-1
Pureza:  99.52%
Synonyms: GSK3235025
Áreas de investigación:  

Cancer

EPZ015666 (GSK3235025) is an orally available inhibitor of PRMT5 with an IC50 of 22 nM.
loading...
    loading...